Moody, David E <br/><br/>
Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.  [electronic resource] 

 -  Journal of analytical toxicology  Jun 2015 
 - 374-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1945-2403 
<br/><br/><label>Standard No.: </label>10.1093/jat/bkv030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Analgesics, Opioid--metabolism<br/>Antifungal Agents--administration & dosage<br/>Azoles--administration & dosage<br/>Biotransformation<br/>Buprenorphine--metabolism<br/>Chromatography, Liquid<br/>Cytochrome P-450 Enzyme Inhibitors--administration & dosage<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Humans<br/>Isoenzymes<br/>Kinetics<br/>Liver--drug effects<br/>Methadone--metabolism<br/>Microsomes, Liver--drug effects<br/>Models, Biological<br/>Molecular Structure<br/>Oxycodone--metabolism<br/>Recombinant Proteins--metabolism<br/>Risk Assessment<br/>Spectrometry, Mass, Electrospray Ionization<br/>Structure-Activity Relationship<br/>Substrate Specificity<br/>Tandem Mass Spectrometry